Related Experiment Videos
Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors
1Analytische Chemie der Technischen Universität, Berlin-West Germany.
Arzneimittel-Forschung
|March 1, 1989
Summary
Water-soluble ferricenium complexes show significant antitumor activity against B16 melanoma and colon 38 carcinoma. Ferricenium trichloroacetate and ferricenium mu-oxo-bis(trichloroferrate) exhibited the best anticancer properties in these tumor models.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Ferricenium complexes are organometallic compounds with potential therapeutic applications.
- Investigating novel compounds for cancer treatment remains a critical area of research.
Purpose of the Study:
- To evaluate the antitumor activity of water-soluble ferricenium complexes against various solid tumors.
- To identify specific ferricenium compounds with potent anticancer properties.
Main Methods:
- Four water-soluble ferricenium complexes were synthesized and tested.
- Antitumor activity was assessed against solid sarcoma 180, B16 melanoma, and colon 38 adenocarcinoma tumor models.
- Tumor growth inhibition and T/C ratios were determined to quantify efficacy.
Main Results:
- Compounds showed marginal activity against sarcoma 180.
- Significant growth inhibition was observed for B16 melanoma (35-60%) and colon 38 adenocarcinoma (50-73%).
- Ferricenium trichloroacetate (IV) and ferricenium mu-oxo-bis(trichloroferrate) (II) demonstrated the best antitumor properties.
Conclusions:
- Water-soluble ferricenium complexes, particularly IV and II, possess notable antitumor activity against specific cancer models.
- These findings suggest potential for further development of ferricenium-based anticancer agents.